• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌预后及相关风险因素分析:一项长期回顾性队列研究。

Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study.

机构信息

Xiangya School of Public Health, Central South University, No. 238 Shang Ma Yuan Ling Road, Changsha, 410008, Hunan, China.

Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan, China.

出版信息

Sci Rep. 2022 Aug 17;12(1):13994. doi: 10.1038/s41598-022-17733-8.

DOI:10.1038/s41598-022-17733-8
PMID:35978078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9385852/
Abstract

This study aims to explore the recurrence rate and overall survival for patients with cervical cancer after the first treatment and the related risk factors. A retrospective cohort study was conducted on cervical cancer patients enrolled in a cancer specialist hospital in Hunan Province, China from January 1992 to December 2005 and followed up until December 2010. Kaplan-Meier survival analysis was used to estimate the cumulative recurrence rate, and Cox proportional hazards model was utilized to identify risk factors associated with prognosis. A total of 4358 patients were enrolled with a median follow-up of 7.4 years (range 5-19 years), and 372 (8.5%) patients had cancer recurrence. The cumulative recurrence rate showed a rapid increase from 3.8% in the first year after discharge to 8.0% in the fifth year, and the recurrence rate remained relatively stable afterward reaching 9.7% and 10.8% in the 10th and the 15th year, respectively. The median time to recurrence was 15.5 months with an IQR of 5.5-40.0 months. The Cox regression showed that miscarriage, clinical stage, and treatment received were significantly associated with cervical cancer recurrence after adjustment for confounders. Patients with recurrence showed a significantly higher risk for mortality than those without recurrence (HR 2.79, 95% CI 2.42-3.22). This study depicted the long-term recurrence rate and survival after recurrence for patients with cervical cancer after the first treatment, and reported time to recurrence and risk factors related to recurrence. These findings may provide important evidence for designing targeted interventions for the treatment of cervical cancer.

摘要

本研究旨在探讨首次治疗后宫颈癌患者的复发率和总生存率及其相关危险因素。采用回顾性队列研究方法,纳入了 1992 年 1 月至 2005 年 12 月在湖南省某癌症专科医院接受治疗并随访至 2010 年 12 月的宫颈癌患者。采用 Kaplan-Meier 生存分析法估计累积复发率,采用 Cox 比例风险模型识别与预后相关的危险因素。共纳入 4358 例患者,中位随访时间为 7.4 年(5-19 年),372 例(8.5%)患者发生癌症复发。复发累积率在出院后第 1 年迅速上升至 3.8%,第 5 年达到 8.0%,此后相对稳定,在第 10 年和第 15 年分别达到 9.7%和 10.8%。复发中位时间为 15.5 个月(IQR:5.5-40.0 个月)。Cox 回归分析显示,流产史、临床分期和治疗方法与调整混杂因素后的宫颈癌复发显著相关。复发患者的死亡风险明显高于未复发患者(HR:2.79,95%CI:2.42-3.22)。本研究描述了首次治疗后宫颈癌患者的长期复发率和复发后的生存率,并报告了复发时间和与复发相关的危险因素。这些发现可能为宫颈癌的治疗提供重要的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a04f/9385852/762527133ad1/41598_2022_17733_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a04f/9385852/57fc3cde9322/41598_2022_17733_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a04f/9385852/c551128990d0/41598_2022_17733_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a04f/9385852/762527133ad1/41598_2022_17733_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a04f/9385852/57fc3cde9322/41598_2022_17733_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a04f/9385852/c551128990d0/41598_2022_17733_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a04f/9385852/762527133ad1/41598_2022_17733_Fig3_HTML.jpg

相似文献

1
Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study.宫颈癌预后及相关风险因素分析:一项长期回顾性队列研究。
Sci Rep. 2022 Aug 17;12(1):13994. doi: 10.1038/s41598-022-17733-8.
2
[Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].[根治性子宫切除术治疗复发性Ⅰb-Ⅱa期宫颈鳞癌的预后因素及治疗模式分析]
Zhonghua Fu Chan Ke Za Zhi. 2019 Jun 25;54(6):399-405. doi: 10.3760/cma.j.issn.0529-567x.2019.06.008.
3
Influencing factors and risk prediction model for cervical cancer recurrence.宫颈癌复发的影响因素及风险预测模型。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Dec 28;47(12):1711-1720. doi: 10.11817/j.issn.1672-7347.2022.210722.
4
Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.采用国际妇产科联盟(FIGO)2018年宫颈癌分期系统的现代放射治疗时代的肿瘤学结局
Gynecol Oncol. 2021 Aug;162(2):277-283. doi: 10.1016/j.ygyno.2021.05.023. Epub 2021 May 29.
5
[Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].[I a2-II a2期宫颈癌腹腔镜与开腹根治性子宫切除术后的长期肿瘤学结局:一项配对队列研究]
Zhonghua Fu Chan Ke Za Zhi. 2015 Dec;50(12):894-901.
6
Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia.沙特阿拉伯一家三级医疗中心接受宫颈癌治疗的女性的生存指标和预后因素
Ann Saudi Med. 2020 Jan-Feb;40(1):25-35. doi: 10.5144/0256-4947.2020.25. Epub 2020 Feb 6.
7
The predictive recurrence value of MTV-s as an 18F-FDG PET/CT index in patients with IIB-IVA cervical cancer.MTV-s 作为 18F-FDG PET/CT 指标对 IIB-IVA 期宫颈癌患者的预测复发价值。
Postgrad Med. 2021 May;133(4):436-443. doi: 10.1080/00325481.2021.1894823. Epub 2021 Mar 15.
8
Class II versus Class III radical hysterectomy in early cervical cancer: an observational study in a tertiary center.早期宫颈癌中 II 类与 III 类广泛性子宫切除术的比较:一家三级中心的观察性研究。
Eur J Surg Oncol. 2014 Jul;40(7):883-90. doi: 10.1016/j.ejso.2014.02.229. Epub 2014 Feb 25.
9
A survival study of uterine cervical patients in the North East India: Hospital-cancer registry-based analysis.印度东北部子宫颈癌患者的生存研究:基于医院癌症登记处的分析。
J Cancer Res Ther. 2018 Jul-Sep;14(5):1089-1093. doi: 10.4103/0973-1482.184516.
10
[Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].[新辅助化疗联合根治性子宫切除术治疗无高危因素的Ⅰb2期和Ⅱa2期宫颈鳞癌的预后分析]
Zhonghua Fu Chan Ke Za Zhi. 2018 Apr 25;53(4):248-256. doi: 10.3760/cma.j.issn.0529-567x.2018.04.008.

引用本文的文献

1
High SNHG expression may contribute to poor cervical cancer prognosis, based on systematic reviews and meta-analyses.基于系统评价和荟萃分析,SNHG高表达可能导致宫颈癌预后不良。
BMC Cancer. 2025 Aug 21;25(1):1350. doi: 10.1186/s12885-025-14497-y.
2
Sacral Neuromodulation for Post-Hysterectomy Hydroureteronephrosis in a Patient with Cervical Cancer: A Case Report.宫颈癌患者子宫切除术后输尿管肾积水的骶神经调节:一例报告
Am J Case Rep. 2025 Jul 26;26:e948967. doi: 10.12659/AJCR.948967.
3
Downregulation of and its prognostic significance in squamous cell carcinoma of the cervix: a bioinformatics analysis based on public datasets.

本文引用的文献

1
Prognosis of Early Stage Cervical Cancer According to Patterns of Recurrence.早期宫颈癌复发模式的预后
Cancer Manag Res. 2021 Oct 28;13:8131-8136. doi: 10.2147/CMAR.S314384. eCollection 2021.
2
Clinical outcomes observation in stage IIB-IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy.同期放化疗后辅助手术治疗 IIB-IIIB 期宫颈癌的临床结局观察。
BMC Cancer. 2021 Apr 21;21(1):442. doi: 10.1186/s12885-021-08146-3.
3
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
在子宫颈鳞状细胞癌中[具体基因或因子名称]的下调及其预后意义:基于公共数据集的生物信息学分析
Transl Cancer Res. 2025 Jul 30;14(7):4034-4045. doi: 10.21037/tcr-2025-307. Epub 2025 Jul 25.
4
Integrating Clinical and Transcriptomic Profiles Associated with Vitamin D to Enhance Disease-Free Survival in Cervical Cancer Recurrence Using the CatBoost Algorithm.整合与维生素D相关的临床和转录组学特征,使用CatBoost算法提高宫颈癌复发患者的无病生存率。
Diagnostics (Basel). 2025 Jun 21;15(13):1579. doi: 10.3390/diagnostics15131579.
5
Comparative study of five-year cervical cancer cause-specific survival prediction models based on SEER data.基于监测、流行病学和最终结果(SEER)数据的五年期宫颈癌特定病因生存预测模型的比较研究
Sci Rep. 2025 Jul 2;15(1):22465. doi: 10.1038/s41598-025-04540-0.
6
'Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer model by targeting the AKT-USP15/USP11-HPV16 E6/E7 axis.奈非那韦通过靶向AKT-USP15/USP11-HPV16 E6/E7轴,使一种具有临床相关性的化疗和放疗抵抗性宫颈癌模型变得敏感。
Biochem Biophys Rep. 2025 Apr 4;42:101987. doi: 10.1016/j.bbrep.2025.101987. eCollection 2025 Jun.
7
Predictors of distant metastasis or local recurrent after radiotherapy in patients with cervical cancer.宫颈癌患者放疗后远处转移或局部复发的预测因素。
BMC Cancer. 2025 Feb 27;25(1):364. doi: 10.1186/s12885-024-13282-7.
8
Survival status of women with cervical cancer in Sub-Saharan Africa: a systematic review and meta-analysis, 2024.撒哈拉以南非洲地区宫颈癌女性的生存状况:一项系统评价与荟萃分析,2024年
Front Oncol. 2025 Jan 7;14:1491840. doi: 10.3389/fonc.2024.1491840. eCollection 2024.
9
The Association Between D-Dimer Levels and Recurrence in Patients with Early-Stage Cervical Cancer after Surgical Treatment.D - 二聚体水平与早期宫颈癌患者手术治疗后复发之间的关联
Int J Womens Health. 2024 Dec 27;16:2333-2342. doi: 10.2147/IJWH.S481692. eCollection 2024.
10
Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival.用于预测宫颈癌复发和生存的双向递归神经网络方法
Sci Rep. 2024 Dec 30;14(1):31641. doi: 10.1038/s41598-024-80472-5.
《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
4
Analysis of pathological and clinical characteristics of cervical conization according to age group in Japan.日本不同年龄组宫颈锥切术的病理及临床特征分析
Heliyon. 2020 Oct 8;6(10):e05193. doi: 10.1016/j.heliyon.2020.e05193. eCollection 2020 Oct.
5
NCCN Guidelines Insights: Cervical Cancer, Version 1.2020.NCCN 指南解读:宫颈癌,第 1.2020 版。
J Natl Compr Canc Netw. 2020 Jun;18(6):660-666. doi: 10.6004/jnccn.2020.0027.
6
Short-term recurrence and distant metastasis following robotic-assisted radical hysterectomy with pelvic lymphadenectomy and chemoradiotherapy for a stage IB1 cervical adenocarcinoma: A case report and literature review.机器人辅助根治性子宫切除术联合盆腔淋巴结清扫术及放化疗治疗ⅠB1期宫颈腺癌后的短期复发和远处转移:1例病例报告及文献复习
Medicine (Baltimore). 2019 Apr;98(17):e15387. doi: 10.1097/MD.0000000000015387.
7
Cervical cancer.宫颈癌。
Lancet. 2019 Jan 12;393(10167):169-182. doi: 10.1016/S0140-6736(18)32470-X.
8
Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years.二十一世纪宫颈癌管理:妇科肿瘤学组/ NRG 肿瘤学过去二十年来的历史视角。
Gynecol Oncol. 2018 Sep;150(3):391-397. doi: 10.1016/j.ygyno.2018.06.023. Epub 2018 Jun 27.
9
Prognostic evaluation of postoperative adjuvant therapy for operable cervical cancer: 10 years' experience of National Cancer Center in China.可手术宫颈癌术后辅助治疗的预后评估:中国国家癌症中心10年经验
Chin J Cancer Res. 2017 Dec;29(6):510-520. doi: 10.21147/j.issn.1000-9604.2017.06.05.
10
Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.2005-2013 年丹麦宫颈癌妇女的复发风险、预后和随访:一项全国队列研究。
Cancer. 2018 Mar 1;124(5):943-951. doi: 10.1002/cncr.31165. Epub 2017 Dec 6.